The Growth Potential of the Pharmacy Automation Systems Market

The pharmacy automation systems market in Europe is experiencing a tremendous growth spurt. Until recently, most pharmacies have been either without automation or have employed very basic automation systems. In response, the adoption rate of automation systems across Europe has been progressing from basic prescription management systems to advanced medication pick-up and drug dispensing automation systems. Likewise, although the adoption of automation systems has been most prevalent among hospital pharmacies, there is significant potential for growth in the retail pharmacy market across Europe.

New analysis from Frost & Sullivan (http://www.healthcareIT.frost.com), European Markets for Pharmacy Automation Systems, finds that the market earned revenues of $151.4 million in 2009 and estimates this to reach $360.2 million by 2016. This research service particularly focuses on prescription management automation systems, medication pick-up automation systems and drug dispensing automation systems.

"Pharmacy automation systems translate a product-centric pharmacy model into a patient-centric workflow model, thus improving the pharmacy environment for both the patients and the pharmacists," says Frost & Sullivan Industry Analyst S. Priyan. "More importantly, these systems reduce the waiting time for the patients, lower medication errors, prevent adverse drug events (ADE), and ease operating costs for the pharmacy, thereby enhancing patient safety, pharmacy productivity, and turnover."

There is considerable demand and potential for automation systems among retail pharmacies. Although the annual maintenance charges of automation systems are one of the least in the healthcare IT market in Europe, the revenues of pharmacy automation systems market are expected to more than double only by 2016.

However, diverse adoption characteristics among the various pharmacy groups in Europe result in slow market growth. Furthermore, the availability of varied information systems in the market for pharmacy workflows tends to confuse the end users, resulting in reduced penetration rates.

"There are several information systems available for pharmacy deployment in Europe such as pharmacy management systems, pharmacy information systems, and electronic prescribing systems," explains Priyan. "These systems reduce the market potential for advanced pharmacy automation systems as the end users make do with these basic workflow automation systems to meet the automation requirements of their pharmacy."

Standardising and consolidating delivery models for various pharmacy groups will help in increasing penetration rates. Organising workshops designed to educate end users on the systems' capabilities, and convening meetings to understand their requirements for offering customised solutions, will promote customer satisfaction, and thereby expand the customer base.

If you are interested in more information on this study, please send an e-mail to Katja Feick, Corporate Communications, at This email address is being protected from spambots. You need JavaScript enabled to view it. with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.

European Markets for Pharmacy Automation Systems is part of the Healthcare & Life Sciences IT Growth Partnership Services programme, which also includes research in the following markets: European Markets for Business Analytics in Healthcare, Electronic Medical Records Market in Europe, and Strategic Analysis of Care Management Market in Europe. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

European Markets for Pharmacy Automation Systems (M567)

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...